Dermabon Multi Symptom Psoriasis Control Soap
FDA Label NDC 49758-001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Dermabon De Chihuahua, S.a. De C.v. for the product Dermabon Multi Symptom Psoriasis Control (NDC 49758-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts, active ingredients, purposes, uses, warnings, do not use, directions, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Drug Facts

Active Ingredients

Coal Tar / 2.13%

Purposes

Anti-Psoriasis / Anti-Dandruff

Uses

For the relief of psoriasis and dandruff

Warnings

  • For external use only.
  • Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.
  • If condition worsens or does not improve after regular use of this product as directed, consult a doctor.
  • Use caution when exposing skin to sunlight after applying this product, it may increase your tendency to sunburn up to 24 hours after application.

Do Not Use

  • for prolonged periods without consulting a doctor.
  • do not use this proudct with other forms of psoriasis therapy, such as ultraviolet radiation or prescription drugs, unless directed to do so by a doctor.
  • If condition covers a large area of the body, consult your doctor before using this product. 

Directions

Apply in affected areas, let it rest, and rinse.

Inactive Ingredients

Borax, Ethyl Alcohol, Glycerin, Glyceryl Stearate, Lanolin, Methylparaben, Sodium Hypoochlorite, Stearic Acid, Petrolatum Oil, Vitamin E, Soap base and Water.

Package Labeling:

Label (Label)

Label (Label)

* Please review the disclaimer below.